Víctor Manuel Infante Viñolo
Chairman chez BIOTECHNOLOGY ASSETS, S.A.
Profil
Víctor Manuel Infante Viñolo is the founder of Bioorganic Research & Services SA. He currently holds the position of Chairman & Director-Business Development at Biotechnology Assets SA, Director at Asociacion De Empresas Biotecnologicas, and Trustee at Corporacion Tecnologica de Andalucia.
In the past, he served as the Chief Executive Officer at Biobide SL and Zera Intein Protein Solutions SL.
Postes actifs de Víctor Manuel Infante Viñolo
| Sociétés | Poste | Début |
|---|---|---|
| BIOTECHNOLOGY ASSETS, S.A. | Chairman | - |
Asociacion De Empresas Biotecnologicas
 Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Director/Board Member | - |
| Corporacion Tecnologica de Andalucia | Director/Board Member | - |
Anciens postes connus de Víctor Manuel Infante Viñolo
| Sociétés | Poste | Fin |
|---|---|---|
Biobide SL
 Biobide SL Miscellaneous Commercial ServicesCommercial Services Biobide is a biotechnology company focused on automated High Throughput Screening (HTS) of potential new drugs. Its goal is to introduce a different service-screening concept into the market by using the zebrafish (Danio rerio) as a model organism. Biobide was founded in June 2005 in order to resolve the main problem acing that contemporary biotechnological and pharmaceutical companies were facing: how to deal with the low success rate in marketing new drugs. Biobide offers a marked improvement in the success rate of new drug research and development through its own quick, efficient and reliable screening system, providing substantially more / better information about potential drugs. | Chief Executive Officer | - |
Zera Intein Protein Solutions SL
 Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Chief Executive Officer | - |
Bioorganic Research & Services SA
 Bioorganic Research & Services SA Medical SpecialtiesHealth Technology Bioorganic Research & Services SA engages in the research and development of biopharmaceutical products for the veterinarian sector. Its portfolio includes vaccines, recombinant proteins and antibodies. The company was founded on March 1, 2005 and is headquartered in Cádiz, Spain. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOTECHNOLOGY ASSETS, S.A. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biobide SL
Biobide SL Miscellaneous Commercial ServicesCommercial Services Biobide is a biotechnology company focused on automated High Throughput Screening (HTS) of potential new drugs. Its goal is to introduce a different service-screening concept into the market by using the zebrafish (Danio rerio) as a model organism. Biobide was founded in June 2005 in order to resolve the main problem acing that contemporary biotechnological and pharmaceutical companies were facing: how to deal with the low success rate in marketing new drugs. Biobide offers a marked improvement in the success rate of new drug research and development through its own quick, efficient and reliable screening system, providing substantially more / better information about potential drugs. | Commercial Services |
Bioorganic Research & Services SA
Bioorganic Research & Services SA Medical SpecialtiesHealth Technology Bioorganic Research & Services SA engages in the research and development of biopharmaceutical products for the veterinarian sector. Its portfolio includes vaccines, recombinant proteins and antibodies. The company was founded on March 1, 2005 and is headquartered in Cádiz, Spain. | Health Technology |
| Corporacion Tecnologica de Andalucia | |
Zera Intein Protein Solutions SL
Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Health Technology |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Health Technology |
